Romidepsin enhances the cytotoxicity of fludarabine, clofarabine and busulfan combination in malignant T-cells

Novel approaches to pre-transplant conditioning are needed to improve treatment of advanced T-cell malignancies. We investigated the synergism of fludarabine (Flu), clofarabine (Clo), busulfan (Bu), and romidepsin (Rom) in T-cell lines and patient-derived cell samples. [Flu+Clo+Bu+Rom] had combinati...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Leuk Res
Huvudupphovsmän: Valdez, Benigno C., Brammer, Jonathan E., Li, Yang, Murray, David, Teo, Esmeralda C., Liu, Yan, Hosing, Chitra, Nieto, Yago, Champlin, Richard E., Andersson, Borje S.
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2016
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4961533/
https://ncbi.nlm.nih.gov/pubmed/27294334
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.leukres.2016.05.019
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk